SELL YOUR PRODUCTS
*mymedicalexpo  
English

Cervical cancer rapid diagnostic test Aptima HPV assay
HPV

cervical cancer rapid diagnostic test
cervical cancer rapid diagnostic test
Add to favorites
Compare this product

Characteristics

Applications
for cervical cancer
Tested parameter
HPV

Description

The Aptima HPV assay offers a unique screening approach by targeting high-risk human papillomavirus (HPV) mRNA from the E6/E7 oncogenes. The Aptima HPV assay offers the same excellent sensitivity and improved specificity as compared to DNA-based tests. About HPV is responsible for more than 99% of all cervical cancers, which is one of the most common types of cancer affecting women throughout the world.1-3 The Aptima HPV assay identifies high-risk HPV infections by targeting E6/E7 mRNA.4 Studies show that targeting E6/E7 mRNA identifies the presence and activity of a high-risk HPV infection.5,6 The Aptima HPV assay represents the next generation in cervical cancer screening - allowing clinicians to deliver maximum benefits to patients, while minimizing potential harm.

Catalogs

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.